Related Experiment Video

Updated: Jul 18, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

Chronic caffeine consumption exacerbates hypertension in rats with polycystic kidney disease

G A Tanner1, J A Tanner

  • 1Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN 46202, USA. gtanner@iupui.edu

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|October 31, 2001
PubMed

Insights

Chronic caffeine intake worsened hypertension in an autosomal dominant polycystic kidney disease (ADPKD) rat model, increasing mean arterial blood pressure. Researchers suggest ADPKD patients limit daily coffee consumption.

Area of Science:

  • Nephrology
  • Pharmacology
  • Genetics

Background:

  • Autosomal dominant polycystic kidney disease (ADPKD) is a prevalent inherited condition often leading to kidney failure and hypertension.
  • Understanding factors influencing ADPKD progression and associated complications is crucial for patient management.

Purpose of the Study:

  • To investigate the impact of chronic caffeine consumption on renal structure, function, and blood pressure in an animal model of ADPKD.
  • To determine if caffeine exacerbates hypertension in the context of polycystic kidney disease.

Main Methods:

  • Male Han:Sprague-Dawley rats with ADPKD and normal littermates were administered either tap water or caffeine solutions from one month of age.
  • At six months, glomerular filtration rate (GFR) and mean arterial blood pressure (MAP) were measured under anesthesia.
  • Cyst development was also assessed in the kidneys.

Main Results:

  • Caffeine intake did not significantly alter GFR or cyst development in rats with ADPKD.
  • Rats with ADPKD exhibited higher MAP compared to normal rats.
  • Chronic caffeine consumption led to a greater increase in MAP in ADPKD rats compared to controls.
  • The hypertensive effect of caffeine was not attributed to direct angiotensin II pressor effects.

Conclusions:

  • Caffeine intake exacerbates hypertension in an animal model of ADPKD.
  • These findings suggest that patients with ADPKD may benefit from limiting their daily intake of caffeinated coffee.
  • Further human studies are warranted to confirm these observations and establish definitive dietary recommendations.

More Related Videos

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...